SCHEMBL2111872

SCHEMBL2111872

C/C=C\SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL385630 1.00
SCHEMBL4624933 1.00
SCHEMBL9518242 0.75
SCHEMBL9518230 0.75
SCHEMBL9518232 0.75
SCHEMBL17750806 0.72
SCHEMBL3505599 0.67
SCHEMBL5163781 0.67
SCHEMBL776480 0.67
SCHEMBL9609156 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250052738-A1 BIOMARKER UNIVERSITY OF LEICESTER (GB) 2025-02-13 US claimed
CN-117831756-B Auxiliary analysis method, device, equipment and storage medium for cognitive impairment 精智未来(广州)智能科技有限公司 2024-06-28 CN claimed
CN-117831756-A Auxiliary analysis method, device, equipment and storage medium for cognitive impairment 精智未来(广州)智能科技有限公司 2024-04-05 CN claimed
US-20210128016-A1 METHODS FOR DIAGNOSING MALARIA WASHINGTON UNIVERSITY (US) 2021-05-06 US claimed
US-10701931-B2 Mosquito activating formulations COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2020-07-07 US claimed
US-20190208777-A1 MOSQUITO ACTIVATING FORMULATIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2019-07-11 US claimed
US-10101319-B2 Methods of detecting plasmodium infection COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2018-10-16 US claimed
EP-3361867-A1 MOSQUITO ACTIVATING FORMULATIONS Commonwealth Scientific and Industrial Research Organisation (AU) 2018-08-22 EP claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
WO-2017063046-A1 MOSQUITO ACTIVATING FORMULATIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-04-20 WO claimed
US-20170045495-A1 METHODS OF DETECTING PLASMODIUM INFECTION COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-02-16 US claimed
EP-3540420-B1 ELECTRONIC DEVICE AND CONTROL METHOD THEREFOR SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-25 EP disclosed
EP-3280541-B1 DIGITALLY CONTROLLABLE SCENT CREATION AND DELIVERY APPARATUS UNIV CALIFORNIA (US) 2025-12-03 EP disclosed
US-12458918-B2 Process and apparatus for treating methane-containing gas KANADEVIA INOVA AG (CH) 2025-11-04 US disclosed
US-20250262341-A1 SWITCHABLE DIGITAL SCENT GENERATION AND RELEASE, AND VAPOR AND LIQUID DELIVERY METHODS AND SYSTEMS UNIV CALIFORNIA (US) 2025-08-21 US disclosed
EP-1465900-B1 RHO-KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2008-05-14 EP disclosed
US-20080027239-A1 Process For The Racemoselective Synthesis Of Ansa-Metallocenes BASELL POLYOLEFINE GMBH (DE) 2008-01-31 US disclosed
US-4301278-A BY HYDROGENATION IN THE PRESENCE OF A CATALYST CIBA-GEIGY CORPORATION (US) 1981-11-17 US disclosed
US-4255328-A CEPHALOSPORINS CIBA-GEIGY CORPORATION (US) 1981-03-10 US disclosed
US-4147864-A Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds CIBA-GEIGY CORPORATION (US) 1979-04-03 US disclosed